Edan Instruments

Edan Instruments EPS Growth

The EPS Growth of Edan Instruments (300206.SZ) as of Oct 25, 2026 is 88.44 %. In the previous year, EPS Growth was -26.78 % — a change of -430.18% (higher).

EPS Growth

88.44 %

YoY

-430.18%

Last updated:

EPS Growth of Edan Instruments is 2025 88.44 % . EPS Growth of Edan Instruments was 2024 -26.78 % . It decreases by -430.18% higher compared to the previous year.

The Edan Instruments EPS Growth history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS Growth
Date
EPS Growth
Jan 1, 2018
112.08 CNY
Jan 1, 2019
42.79 CNY
Jan 1, 2020
396.21 CNY
Jan 1, 2021
-64.51 CNY
Jan 1, 2022
1.76 CNY
Jan 1, 2023
-5.79 CNY
Jan 1, 2024
-26.78 CNY
Jan 1, 2025
88.44 CNY
The Edan Instruments EPS Growth history
YEAREPS GrowthYoY
88.44 %-430.18%
-26.78 %+362.77%
-5.79 %-429.78%
1.76 %-102.72%
-64.51 %-116.28%
396.21 %+825.84%
42.79 %-61.82%
112.08 %+67.99%
66.72 %-189.44%
-74.60 %-112.14%
614.40 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Edan Instruments Stock analysis

What does Edan Instruments do? Edan Instruments, Inc. generates revenue through the design, manufacture, and sale of medical equipment, including maternity product series like doppler fetal heart beat monitors, ultrasonic doppler fetal heart beat monitors, fetal/maternal monitors, and maternity integrated diagnostic monitoring systems. The company also sells electrocardiograph series such as digital twelve-channel electrocardiographs, digital six-channel electrocardiographs, and electrocardiographic workstations, along with monitoring products like portable multi-variable monitors and central monitoring systems. Additionally, Edan offers spare parts and in vitro diagnostics products to support its equipment and medical services. The primary buyers of Edan's products are healthcare institutions, including hospitals and clinics, which purchase medical devices for diagnostic and monitoring purposes. These institutions rely on Edan's maternity, electrocardiograph, and monitoring systems to provide patient care. The company's in vitro diagnostics products are also sold to medical facilities for laboratory testing needs. Edan's product segments are defined by medical equipment categories: maternity, electrocardiograph, monitoring, and ultrasonic image systems. The spare parts and in vitro diagnostics businesses complement these segments by providing essential accessories and diagnostic tools. Revenue is derived from direct sales of these products to healthcare providers, with no mention of third-party distribution or additional services beyond the described offerings. Edan Instruments is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Edan Instruments stock

EPS Growth of Edan Instruments is 88.44 % in 2025.

On Eulerpool you can find the complete historical development of EPS Growth Edan Instruments since 2006 – with annual values, charts, and detailed analysis.

EPS growth measures the percentage change in earnings per share. It accounts for both profit changes and share count changes.

To evaluate EPS Growth's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EPS Growth.

EPS Growth's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EPS Growth's Edan Instruments historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Growth — Edan Instruments

All Key Metrics — Edan Instruments